Vitrolife

Vitrolife stands as a global leader in reproductive health, dedicated to supporting successful treatment outcomes for fertility clinics worldwide. Since its establishment in 1994, Vitrolife has been committed to pioneering advancements in IVF, consistently delivering products of superior quality. Vitrolife aims to enable people to fulfill the dream of having a healthy baby.

With its primary address at Gustaf Werners gata 2, Västra Frölunda, 421 32, SE, and additional locations including 3601 South Inca Street, Englewood, CO 80110, US; 6835 Flanders Drive, Suite 500, San Diego, CA 92121, US; Ruyen Building 2F, 1-3-1 Shibakoen, Tokyo, Minato-ku 105-0011, JP; Jens Juuls Vej 20, Aarhus, Middle Jutland 8260, DK; Focus Square No. 6, Futong East Avenue, Beijing, Chaoyang District 100121, CN; Rödersteinstr. 6, Bruckberg, Landshut D-84034, DE; 68 Pitt St, Level 10, Sydney, New South Wales 2000, AU; Via Pistrucci, 26, Milan, Milan 20137, IT; and 1 Chapel Street, Warwick, CV34 4HL, GB, Vitrolife provides comprehensive support to customers across more than 110 countries, blending innovation with sustainability. Following the acquisition of Igenomix in 2021, Vitrolife Group integrates advanced reproductive genetic testing services with its best-in-class IVF device portfolio, offering complete solutions for the entire fertility journey.

Vitrolife's mission is to be the leading global partner in reproductive health, striving for better treatment outcomes for patients. Based on science and advanced research capabilities, Vitrolife aims to deliver products and services for the entire fertility journey, providing consistent performance and guaranteed quality. Vitrolife continues to innovate and expand, ensuring it remains at the forefront of reproductive technology. We invite the manager of Vitrolife to create a customized and exclusive company showcase and product listing on our platform to further highlight your offerings.